Alice in Wonderland Syndrome (AIWS) – Likely Diagnosis
This 5-year-old is most likely experiencing Alice in Wonderland Syndrome (AIWS), a benign neuropsychiatric phenomenon characterized by transient visual distortions, particularly micropsia (seeing objects or people as smaller than they are), which typically resolves spontaneously without intervention.
Clinical Reasoning
The presentation is classic for AIWS:
- Brief, sporadic episodes of micropsia (seeing people with "smaller heads")
- Self-limited (5 minutes, resolves spontaneously)
- No distress to the child (retained insight and orientation)
- Age-appropriate (AIWS typically affects young children, average age 8.1 years) 1
Micropsia is the most common visual symptom in AIWS, occurring in 69% of cases 1. The brief, transient nature and lack of associated neurological deficits strongly support this diagnosis over structural lesions or active seizure activity.
Recommended Evaluation
Initial Workup
Perform a targeted history focusing on:
- Recent viral illness (especially Epstein-Barr virus, which is strongly associated with AIWS) 2
- Headache patterns (migraine is associated in 6% of cases initially, though 25% may develop migraines later) 1
- Recent head trauma (6% association) 1
- Family history of migraine
Neuroimaging and EEG Considerations
MRI and EEG are typically unrevealing and not necessary for diagnosis in classic presentations. In the largest pediatric series, MRI was normal in 21/21 cases and EEG was normal in 23/23 cases 1. However, consider these studies if:
- Atypical features are present (prolonged episodes, progressive symptoms, focal neurological deficits)
- Diagnostic uncertainty exists
- Reassurance is needed for family
One case report showed bilateral temporo-occipital slowing on EEG correlating with symptoms 3, but this is exceptional rather than typical.
Laboratory Testing
Consider EBV serology (VCA IgM/IgG and EBNA-1 IgG) given the strong association with post-infectious states, particularly EBV 2. Basic metabolic panel and inflammatory markers can be obtained if infection is suspected, though extensive autoimmune screening is typically low-yield 2.
Management and Prognosis
Reassurance and observation are the primary interventions. No pharmacologic treatment is required for uncomplicated AIWS 2.
Expected Course
- 40% of patients have no further events after initial diagnosis
- 20% have a few more events that eventually stop
- 40% continue to have intermittent symptoms 1
- 27% may develop migraines over time 1
- 7% may develop seizures 1
Follow-up Strategy
- Close outpatient monitoring for 4-6 weeks (typical resolution timeframe) 2
- Educate family about the benign nature and expected spontaneous resolution
- Counsel about potential future development of migraines (1 in 4 risk)
- Instruct to return if symptoms change in character, duration, or frequency
Common Pitfalls to Avoid
Over-investigation: The most common etiology is infection (33%), but 52% have no identifiable trigger 1. Extensive workup is unnecessary in classic presentations.
Misdiagnosis as seizure: While seizures can cause visual distortions, the preserved awareness, lack of post-ictal state, and normal EEGs distinguish AIWS from epileptic phenomena.
Premature medication: Avoid initiating migraine prophylaxis or antiepileptics unless clear indication develops, as most cases resolve spontaneously.
Inadequate reassurance: Family anxiety can be significant. Emphasize the benign, self-limited nature while acknowledging the need for monitoring.